Generally, Phase I trials are conducted over several months (six to nine months) whilst Phase II trials take six months to three years. Phase III trials tend to be of longer duration, lasting one to four years. Phase IV trials are conducted after the new drug has been marketed and the duration of the trials may last two to five years or longer.